The European Asthma Research and Innovation Partnership (EARIP) aims to reduce asthma deaths in Europe by 25% within ten years and by 50% within 20 years. The partnership, made up of 12 European-based organisations, also aims to halve hospital admission rates, speed up the discovery of new treatments and improve self-management. The EARIP project will do this through identifying key gaps in asthma knowledge; it will then address these using a pioneering and integrated approach to research, development and innovation across Europe. Through rapid dissemination of project results, EARIP will ensure that outcomes from knowledge-based asthma research will quickly result in an improved quality of life for people with asthma.
Recent Posts
- Artificial intelligence could revolutionise asthma treatment
- Serum cAMP levels are increased in patients with asthma
- Comparative analysis of ambient, in-home, and personal exposures reveals associations between breathing zone pollutant levels and asthma exacerbations in high-risk children
- Asthma and Memory Function in Children
- Peripheral blood miRNAs are associated with airflow below threshold in children with asthma